Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients

Renal Failure

Volumn 27, Issue 4, 2005, Pages 385-392

  Hein, Ortrud Vargas ^a   Staegemann, M ^a   Wagner, D ^a   Von Heymann, C ^a   Martin, M ^a   Morgera, S ^a   Spies, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aldosterone; ARF; Cardiac surgery; CRRT; Furosemide; Torsemide

Indexed keywords

ALDOSTERONE; CREATININE; ELECTROLYTE; FUROSEMIDE; LOOP DIURETIC AGENT; RENIN; TORASEMIDE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICAL ILLNESS; DIURETIC ACTIVITY; DIURETIC THERAPY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG EFFICACY; ELECTROLYTE BLOOD LEVEL; FEMALE; HEART SURGERY; HEMODIALYSIS; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; SULFONAMIDES; TREATMENT OUTCOME;

EID: 22244436287     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-65298     Document Type: Article

References (24)

1. Vargas, H.O.; von Heymann, C.; Lipps, M.; Ziemer, S.; Ronco, C.; Neumayer, H.H.; Morgera, S.; Welte, M.; Kox, W.J.; Spies, C. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med. 2001, 27, 673-679.
2. Stallwood, M.I.; Grayson, A.D.; Mills, K.; Scawn, N.D. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann. Thorac. Surg., 2004, 77 (3), 968-972.
3. Kellum, J.A.; Angus, D.C.; Johnson, J.P.; Leblanc, M.; Griffin, M.; Ramakrishnan, N.; Linde-Zwirble, W.T. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002, 28 (1), 29-37.
4. Lameire, N.H.; De Vriese, A.S.; Vanholder, R. Prevention and nondialytic treatment of acute renal failure. Curr. Opin. Crit. Care 2003, 9 (6), 481-490.
5. Mehta, R.L.; Pascual, M.T.; Soroko, S.; Chertow, G.M. Diuretics, mortality, and non-recovery of renal function in acute renal failure. JAMA 2002, 288 (20), 2547-2553.
6. Brater, D.C. Diuretic therapy. N. Engl. J. Med. 1998, 339 (6), 387-395.
7. Brater, D.C. Pharmacology of diuretics. Am. J. Med. Sci. 2000, 319 (1), 38-50.
8. Risler, T.; Schwab, A.; Kramer, B.; Braun, N.; Erley, C. Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure. Cardiology 1994, 84 (S2), 155-161.
9. Boesken, W.H.; Kult, J. High-dose torsemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Clin. Nephrol. 1997, 48 (1), 22-28.
10. Uchida, T.; Yamanaga, K.; Kido, H.; Ohtaki, Y.; Watanabe, M. Diuretic and vasodilating actions of torsemide. Cardiology 1994, 84 (S2), 14-17.
11. Uchida, T.; Yamanaga, K.; Nishikawa, M.; Ohtaki, Y.; Kido, H.; Watanabe, M. Anti-aldosteronergic effect of torsemide. Eur. J. Pharmacol. 1991, 205 (2), 145-150.
12. Goodfriend, T.L.; Ball, D.L.; Oelkers, W.; Bahr, V. Torsemide inhibits aldosterone secretion in vitro. Life Sci. 1998, 63 (3), L45-L50.
13. Uechi, M.; Matsuoka, M.; Kuwajima, E.; Kaneko, T.; Yamashita, K.; Fukushima, U.; Ishikawa, Y. The effects of the loop diuretics furosemide and torsemide on diuresis in dogs and cats. J. Vet. Med. Sci. 2003, 65 (10), 1057-1061.
14. Yamato, M.; Sasaki, T.; Honda, K.; Fukuda, M.; Akutagawa, O.; Okamoto, M.; Hayashi, T. Effects of torsemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ. J. 2003, 67 (5), 384-390.
15. Clasen, W.; Khartabil, T.; Imm, S.; Kindler, J. Torsemide for diuretic treatment of advanced chronic renal failure. Arzneim.-Forsch. 1988, 38 (1A), 209-211.
16. Russo, D.; Memoli, B.; Andreucci, V.E. The place of loop diuretics in the treatment of acute and chronic renal failure. Clin. Nephrol. 1992, 38 (S1), S69-S73.
17. Shilliday, I.R.; Quinn, K.J.; Allison, M.E. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol. Dial. Transplant. 1997, 12 (12), 2592-2596.
18. Kox, W.J.; Spies, C. Ckeck-up Anästhesiologie; Kox, W.J., Spies, C., Eds.; Springer Verlag: Berlin, 2003; 3-581.
19. Yelton, S.L.; Gaylor, M.A.; Murray, K.M. The role of continuous infusion loop diuretics. Ann. Pharmacother. 1995, 29 (10), 1010-1014.
20. Kellum, J.A. Diuretics in acute renal failure: protective or deleterious. Blood Purif. 1997, 15 (15), 319-322.
21. Vargas Hein, O.; Spies, C.; Kox, W.J. Renal dysfunction in the perioperative period. In Anaesthesia, Pain, Intensive Care and Emergency Medicine (A.P.I.C.E.); Gullo, A., Ed.; Springer Verlag: Milano, 2000; 309-315.
22. Wang, F.; Dupuis, J.Y.; Nathan, H.; Williams, K. An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery: estimated creatinine clearance or plasma creatinine level as measures of renal function. Chest 2003, 124 (5), 1852-1862.
23. Allison, M.E.; Shilliday, I. Loop diuretic therapy in acute and chronic renal failure. J. Cardiovasc. Pharmacol. 1993, 22 (S3), S59-S70.
24. Fortuno, A.; Muniz, P.; Ravassa, S.; Rodriguez, J.A.; Fortuno, M.A.; Zalba, G.; Diez, J. Torsemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension 1999, 34 (1), 138-143.